Is there any safety data for estradiol

The short version: the evidence here does not compare bioidentical to standard hormones on any hard clinical outcome, so the question of which "works better" remains unanswered by these records.

The retrieval contains zero studies that directly compare bioidentical hormones (estradiol, progesterone) to standard synthetic hormones (conjugated equine estrogens, medroxyprogesterone) on symptoms, safety, or long-term outcomes. What it does contain is a 2014 study showing that micronized transdermal estradiol plus intravaginal progesterone, combined with metformin and other agents, produced histopathologic regression of early endometrial cancer in young women with PCOS [3]. That is a specific therapeutic use, not a comparison of bioidentical versus standard HT for menopause.

The rest of the evidence is about oral contraceptives, synthetic progestins, and coagulation risks [1, 2, 4]—useful for understanding estrogen's thrombotic effects but silent on whether bioidentical formulations change that risk profile. One 2020 review notes that transdermal estradiol has lower VTE and stroke risk than oral estrogens [4], but that is a route-of-administration finding, not a bioidentical-versus-synthetic finding.

What this retrieval cannot see matters. The claim that bioidentical hormones are safer rests on the idea that estradiol and progesterone are "body-identical" and therefore avoid the metabolites and prothrombotic effects of synthetic hormones. That hypothesis is mechanistically plausible—oral synthetic estrogens undergo first-pass hepatic metabolism that raises clotting factors [4]—but no study here tests whether bioidentical formulations actually reduce breast cancer, heart disease, or dementia rates compared to standard HT. The absence of that evidence is not evidence of safety.

My call: the evidence does not show that bioidentical hormones work better than standard HT, because no comparative trial on clinical outcomes was retrieved. The route-of-administration data favoring transdermal over oral [4] is real but applies to both bioidentical and synthetic estrogens. Confidence: low.